From the Back Cover
This book contains a summary of the most important nanocarriers for skin delivery. Although "nanocosmetics" is a subject widely commented in the academy and the beauty industry, a book covering the skin care treatments using nanotechnological approaches with cosmetics and nanomedicines is still missing, therefore the need for this publication. This book is divided in three parts: The first one (Part A) is devoted to a brief review on the main topics related to the skin delivery and to the introduction of the subject "nanocosmetics". The second part (Part B) presents different types of nanocarriers applied as skin delivery systems for cosmetics or drugs. The last part (Part C) shows a wide range of applications of nanotechnology on the skin care area as well as on dermatocosmetic and dermatological fields.
Adriana Raffin Pohlmann is Associate Professor II at the Department of Organic Chemistry in the Institute of Chemistry of UFRGS. She received her PhD in Therapeutic Chemistry at the University of Paris V, France, in 1997. Her main research is focused on the organic chemistry applied to drug nanocarriers, including polymeric nanocapsules and nanospheres, with the view of understanding and controlling their sizes, shape, surface and physico-chemical properties. She was the Vice-Director of one of the Brazilian National Nanotechnology Network (Nanocosmetics Network), and Coordinator of a collaborative IBSA project between India, Brazil and South Africa both supported by the Brazilian Ministry of Science and Technology. She has published more than 100 research papers, 1 book and 5 book chapters, and 4 patents. She is member of the Editorial Board of the Journal of Biomedical Nanotechnology. She is Ad-hoc reviewer for more than 20 Scientific Journals and for National and State Agencies to support scientific research. She is a member of the Brazilian Association of Pharmaceutical Scientists (ABCF) and the Brazilian Chemical Society (SBQ).
Sílvia Stanisçuaski Guterres is a Professor of Pharmaceutical Technology in the College of Pharmacy at the Federal University of Rio Grande do Sul, Brazil, since 1989. She received her PhD in Pharmaceutical Nanotechnology from the University of Paris XI, France, in 1995. Her main research is focused on the development, physicochemical characterization and biological applications of innovative nanocarriers aiming at drug delivery via oral, cutaneous and parenteral routes. She is the Director of one of the Brazilian National Nanotechnology Network (Nanocosmetics Network), supported by the Brazilian Ministry of Science and Technology. She is the Coordinator of a collaborative project between France (Université de Paris-Sud, Professor Elias Fattal) and Brazil (UFRGS) for Nanotechnolgy (CAPES/COFECUB540-2005) supported by the Brazilian Ministry of Education. She has published more than 100 research papers and 6 book chapters. She is a member of the Brazilian Chemical Society (SBQ), the Center of Nanoscience and Nanotechnology (CNANO/UFRGS) and the Brazilian Association of Pharmaceutical Sciences (ABCF). She is member of the Editorial Board of the Journal of Drug Science and Technology.
Ruy Carlos Ruver Beck is a Professor of Pharmaceutical Technology in the College of Pharmacy at the Federal University of Rio Grande do Sul, Brazil, since 2010. He received his PhD in Pharmaceutical Sciences from the Federal University of Rio Grande do Sul, Brazil, in 2005 a with collaborative period in the Saarland University, Germany (Departament of Biopharmacy and Pharmaceutical Technology). His main research is focused on the development, physicochemical characterization and biological applications of innovative nanocarriers aiming at drug delivery via oral, ocular, cutaneous and parenteral routes. He is a member of one of the Brazilian National Nanotechnology Network (Nanocosmetics Network), supported by the Brazilian Ministry of Science and Technology. He has published more than 30 research papers. He is a member of the Center of Nanoscience and Nanotechnology (CNANO/UFRGS) and the Brazilian Association of Pharmaceutical Sciences (ABCF). He is Ad-hoc reviewer for more than 15 Scientific Journals and for State Agencies to support scientific research.
